FINLEY JOHN DAVID (Chief Financial Officer) sold 12.5% of their position (3.90K shares) of PALISADE BIO, INC. on the open market
Open‑market sale worth $6.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/13/2026ACC: 0001493152-26-006831
Officer· Chief Financial Officer
Since Apr 2021
-3.90K
Net shares
Net seller
$6.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.33K acquired · 17.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.33K
Price / share
—
Trade value
—
% of position
74.4%
2/11/2026
17.92K→31.25K
Common Stock
Direct
Shares
−3.90K
Price / share
$1.75
Trade value
$6.82K
% of position
12.5%
2/12/2026
31.25K→27.35K
Total
Net shares
+9.44K
Net value
-$6.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | M · Option Exercise | +13.33K | — | — | 74.4% | 17.92K | 31.25K |
| Common Stock Direct | 2/12/2026 | S · Sale | −3.90K | $1.75 | $6.82K | 12.5% | 31.25K | 27.35K |
| Total | +9.44K | -$6.82K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
13.33K shares
Shares
−13.33K
Strike price
Held after
26.67K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock13.33K shares | 2/11/2026 | M · Option Exercise | −13.33K | — | 26.67K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned51.00
Total
51.00 indirect51.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 51.00 | Indirect |
| Total | 51.00 | 51.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported